Nephro Care India Ltd Financials
Company Logo

Nephro Care India Ltd Financial Statement

Nephro Care India Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Mar 2024
Revenue7.70
Operating Expense6.15
Net Profit1.01
Net Profit Margin13.12
Earning Per Share0.85
EBIDTA1.49
Effective Tax Rate30.32

Nephro Care India Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual27.23
Operating Expenses Annual20.76
Operating Profit Annual6.75
Interest Annual0.09
Depreciation0.53
Net Profit Annual4.41
Tax Annual1.72

Nephro Care India Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning2.32
Cash Flow from Operations0.91
Cash Flow from Investing-7.54
Cash Flow from Financing5.60
Cash Flow at the End1.29

Nephro Care India Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)24.47
PBIT Margin (%)22.54
PBT Margin (%)-227.95
Net PROFIT Margin (%)15.98
Return On Networth / Equity (%)50.26
Return On Networth /Employed (%)61.86
Return On Assets (%)43.80
Total Debt / Equity (X)0.14
Asset Turnover Ratio (%)2.74

Nephro Care India Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual4.74
Total Current Assets Annual4.40
Non Current Assets Annual16.57
Total Shareholders Funds Annual15.03
Total Assets Annual20.97

Nephro Care India Ltd Earning Calls

No Data Availabe

Get Your FAQs Right

As of Oct 9, 2024, Nephro Care India Ltd has a market capitalization of - Cr. Value Research classifies it as a Micro-Cap company.
Yes, Nephro Care India Ltd is debt-free with a debt-to-equity ratio of 0.00.
In FY 2023 , Nephro Care India Ltd recorded a total revenue of approximately 27.23 Cr marking a significant milestone in the company's financial performance.
Nephro Care India Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately NaN% and 1.0% annually, respectively..
Nephro Care India Ltd's current PE ratio is undefined.
Nephro Care India Ltd's ROCE averaged 31.6% from the FY ending March 2022 to 2024, with a median of 41.4%. It peaked at 52.8% in March 2023, reflecting strong capital efficiency over the period..
Nephro Care India Ltd's latest EBIT is Rs. 6.22 Cr, surpassing the average EBIT of Rs. 2.96 Cr over the 5 years..